Novartis loses landmark patent case in India

India’s top court has refused marketing exclusivity for an new form of Glivec on the grounds that it is not a novel medicine but an amended version of an existing compound. The decision means that generic drug makers are now allowed to sell more affordable copies of the cancer treatment to the 1.2 billion people living in India.
WT news feed

Anatomy of a problem — Bitcoin loses 25% in value due to a long-missed bug.

This time, it wasn’t the surrounding ecosystem that turned out to have feet of clay, but the software behind Bitcoin itself. It seems that version 0.7 of the Bitcoin mining software – the program that does the cryptographic guessing, and exchanges blockchains over its peer-to-peer network – had a fatal but unknown flaw.
WT news feed